VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U5856AA: VAERS reports

23 VAERS reports list lot U5856AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2017-10-09 and 2022-08-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
0%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1433%
General / Systemic (non-local)819%
Cardiac / Cardiovascular512%
Musculoskeletal512%
Allergic / Anaphylactic37%
Dermatological (non-injection-site)37%
Neurological25%
Psychiatric / Neuropsychiatric25%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Texas2
Oregon2
Idaho2
New Hampshire1
Colorado1
Ohio1
Nebraska1
Minnesota1
Georgia1
Kansas1
Iowa1

Reports by month received

2017-104
2017-121
2018-021
2018-051
2018-081
2018-112
2019-011
2019-031
2019-061
2019-071
2019-091
2020-023
2020-031
2022-084

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.